These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33381588)

  • 21. PRAME expression in 155 cases of metastatic melanoma.
    Gradecki SE; Slingluff CL; Gru AA
    J Cutan Pathol; 2021 Apr; 48(4):479-485. PubMed ID: 32939793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PRAME expression and clinical outcome of breast cancer.
    Epping MT; Hart AA; Glas AM; Krijgsman O; Bernards R
    Br J Cancer; 2008 Aug; 99(3):398-403. PubMed ID: 18648365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
    Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological and prognostic significance of metastasis-associated in colon cancer-1 (MACC1) overexpression in colorectal cancer: a meta-analysis.
    Zhao Y; Dai C; Wang M; Kang H; Lin S; Yang P; Liu X; Liu K; Xu P; Zheng Y; Li S; Dai Z
    Oncotarget; 2016 Sep; 7(39):62966-62975. PubMed ID: 27542234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic utility of immunohistochemistry in concordance with mRNA analysis of PRAME in the stratification of high-risk uveal melanoma patients.
    Kumar N; Singh MK; Singh L; Lomi N; Meel R; Pushker N; Sen S; Kashyap S
    Hum Cell; 2023 Jan; 36(1):342-352. PubMed ID: 36282437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer testis antigen (PRAME) as an independent marker for survival in oral squamous cell carcinoma (OSCC).
    Haidari S; Tröltzsch M; Fliefel R; Jungbluth AA; Otto S; Fegg F; Liokatis P; Ahmadi N; Eberl M; Probst FA; Knösel T
    J Oral Pathol Med; 2022 May; 51(5):421-428. PubMed ID: 35430758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LAMC2 as a prognostic biomarker in human cancer: a systematic review and meta-analysis.
    Fu T; Liu JX; Xie J; Gao Z; Yang Z
    BMJ Open; 2022 Nov; 12(11):e063682. PubMed ID: 36396303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
    BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer.
    Al-Khadairi G; Naik A; Thomas R; Al-Sulaiti B; Rizly S; Decock J
    J Transl Med; 2019 Jan; 17(1):9. PubMed ID: 30602372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular and clinicopathological implications of PRAME expression in adult glioma.
    Le MK; Vuong HG; Dunn IF; Kondo T
    PLoS One; 2023; 18(10):e0290542. PubMed ID: 37796789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological and prognostic significance of p16 protein in nasopharynx cancer patients: A PRISMA-compliant meta-analysis.
    Sun L; Song J; Huang Q
    Medicine (Baltimore); 2019 Mar; 98(11):e14602. PubMed ID: 30882625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic Value of Melanoma-Associated Antigen-A (MAGE-A) Gene Expression in Various Human Cancers: A Systematic Review and Meta-analysis of 7428 Patients and 44 Studies.
    Poojary M; Jishnu PV; Kabekkodu SP
    Mol Diagn Ther; 2020 Oct; 24(5):537-555. PubMed ID: 32548799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and clinical implications of c-erbB-2 expression in patients with oral cancer: A meta-analysis.
    Meng Y; Yang P; Ma L
    Medicine (Baltimore); 2020 Jun; 99(23):e20575. PubMed ID: 32502026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High lncSNHG15 expression may predict poor cancer prognosis: a meta-analysis based on the PRISMA and the bio-informatics analysis.
    Fang SX; Chen C; Guo Q; Ke XX; Lu HL; Xu G
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis.
    Ji K; Zhang L; Zhang M; Chu Q; Li X; Wang W
    Medicine (Baltimore); 2016 Feb; 95(5):e2641. PubMed ID: 26844481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.
    Pasquali S; Mocellin S; Mozzillo N; Maurichi A; Quaglino P; Borgognoni L; Solari N; Piazzalunga D; Mascheroni L; Giudice G; Patuzzo R; Caracò C; Ribero S; Marone U; Santinami M; Rossi CR
    J Clin Oncol; 2014 Mar; 32(9):935-41. PubMed ID: 24516022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
    Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
    JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.